EVERSANA’s Rohit Sood, Executive Vice President, COMPLETE Commercialization shares the four key performance indicators we focus on with every EVERSANA COMPLETE Commercialization program – Speed, Agility, Consistency and Risk Management.
Check out our whitepaper, CHALLENGING TRADITION: The argument for integrated commercialization to improve operational agility, to learn more about what occurs when pharmaceutical companies:
- lean into evolution and adopt an innovative mindset,
- leverage a fully integrated commercialization model to drive operational excellence,
- harness the energy and momentum in an efficient and accessible package and
- turn away from fixed and sluggish structures and toward more efficient partnerships for success.
Author
Executive Vice President, EVERSANA COMPLETE Commercialization®
Rohit leads the EVERSANA COMPLETE Commercialization® business which consists of a world-class global life sciences commercialization team who drives the execution of our partnered multi-TA portfolio. He is responsible for shaping the commercial structure,…